)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
NewAmsterdam Pharma Company
NewAmsterdam Pharma Company (NAMS) investor relations material
NewAmsterdam Pharma Company Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary11 Feb, 2026
Study updates and timelines
PREVAIL and BROADWAY studies are nearly identical in design, with PREVAIL's event rate at 12 months tracking in line with BROADWAY, which showed a 21% MACE benefit.
An update on PREVAIL's overall timelines will be provided based on continued adjudication of events out to at least two years.
The design paper for PREVAIL is expected to be published this year.
Compliance in PREVAIL is being maintained through enhanced site visits and sharing positive LDL study results to motivate patients.
Adverse events in completed LDL studies were lower on drug than placebo, supporting patient retention.
Drug profile and differentiation
Obicetrapib, alone or with ezetimibe, enables 70%-80% of patients to reach risk-based goals with a convenient once-daily oral pill.
The drug shows benefits beyond LDL reduction, including up to 50% reduction in Lp(a), elimination of small LDL particles, and reduced diabetes incidence.
Recent data suggest a potential role in Alzheimer's disease prevention or treatment.
The drug is positioned as highly differentiated, targeting multiple risk factors beyond LDL-C.
No other drug in development matches its ability to reduce LDL particles by 80%-100%.
Market landscape and commercial strategy
The market opportunity is large, with at least 30 million U.S. patients not at risk-based goals despite treatment.
The commercial team has experience launching drugs in competitive markets and is confident in a successful launch.
Approval in Europe is expected this year, with U.S. regulatory timelines to be provided mid-year.
U.S. launch strategy is tied to having outcomes data public at launch, unlike Europe where pricing timelines differ.
The presence of other oral options is seen as beneficial for raising disease awareness, not as direct competition.
PREVAIL powering assumptions impact
Obicetrapib's non-LDL benefits vs oral PCSK9
Revasc contribution to PREVAIL MACE benefit
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next NewAmsterdam Pharma Company earnings date
Q4 202526 Feb, 2026
NewAmsterdam Pharma Company
Next NewAmsterdam Pharma Company earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
NewAmsterdam Pharma Company N.V. is a clinical-stage biopharmaceutical company based in the Netherlands, focusing on the development of oral and non-statin medicines for patients at high risk of cardiovascular disease. Its leading product candidate is obicetrapib, a next-generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, currently in various stages of clinical trials. The company's mission is aimed at improving patient care in populations with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated, with a significant focus on creating a potent, cost-effective, and convenient LDL-lowering therapy. The company is headquartered in Naarden, the Netherlands, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage